Preclinical animal models of multiple myeloma

Seint T Lwin1, Claire M Edwards2, Rebecca Silbermann3

  • 1Nuffield Department of Surgical Sciences, University of Oxford , Oxford, UK.

Bonekey Reports
|February 25, 2016
PubMed

Insights

Murine models are essential for understanding multiple myeloma (a type of bone cancer) and developing new treatments. This review details various models and provides protocols for their use.

Area of Science:

  • Oncology
  • Immunology
  • Hematology

Background:

  • Multiple myeloma is an incurable plasma-cell malignancy.
  • It is characterized by osteolytic bone disease and immunosuppression.
  • Effective therapeutic strategies require a deeper understanding of disease pathogenesis.

Purpose of the Study:

  • To review commonly used immunocompetent and xenograft murine models for multiple myeloma research.
  • To outline the advantages and disadvantages of each model system.
  • To provide detailed protocols for establishing systemic and local myeloma models.

Main Methods:

  • Review of existing literature on murine models of multiple myeloma.
  • Description of immunocompetent and xenograft model systems.
  • Inclusion of detailed experimental protocols for model establishment.

Main Results:

  • Identification and comparison of various immunocompetent and xenograft models.
  • Discussion of the strengths and limitations of each model.
  • Provision of practical guidance for researchers.

Conclusions:

  • Murine models are critical tools for advancing multiple myeloma research.
  • Selection of an appropriate model depends on specific research questions.
  • Standardized protocols facilitate reproducible research and therapeutic development.